Cargando…
Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
BACKGROUND/PURPOSE: One to three per cent of the world’s population has hepatitis C virus (HCV) infection, which is not only a major cause of liver disease and cancer but also associated with an increased risk of atherosclerosis, despite an ostensibly favourable lipid profile. Autoantibodies are fre...
Autores principales: | Bridge, Simon H., Pagano, Sabrina, Jones, Meleri, Foster, Graham R., Neely, Dermot, Vuilleumier, Nicolas, Bassendine, Margaret F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814532/ https://www.ncbi.nlm.nih.gov/pubmed/29423541 http://dx.doi.org/10.1007/s12072-018-9842-5 |
Ejemplares similares
-
Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis
por: Sheridan, David A., et al.
Publicado: (2022) -
Revisiting the Elusive Hepatitis C Vaccine
por: Todryk, Stephen M., et al.
Publicado: (2021) -
Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014) -
Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
por: Anderson, Josephine L.C., et al.
Publicado: (2019) -
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
por: Pagano, Sabrina, et al.
Publicado: (2015)